Sorena Nadaf

8.0k total citations · 4 hit papers
26 papers, 6.5k citations indexed

About

Sorena Nadaf is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Sorena Nadaf has authored 26 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Immunology and 7 papers in Cancer Research. Recurrent topics in Sorena Nadaf's work include Immunotherapy and Immune Responses (13 papers), Angiogenesis and VEGF in Cancer (6 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Sorena Nadaf is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Angiogenesis and VEGF in Cancer (6 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Sorena Nadaf collaborates with scholars based in United States, South Korea and Iran. Sorena Nadaf's co-authors include David P. Carbone, Dmitry I. Gabrilovich, Tsunehiro Oyama, Tadao Ishida, Sophia Ran, Vladimir Kravtsov, Geralyn M. Meny, Lawrence D. Kerr, Joyce E. Ohm and Brian R. Lindman and has published in prestigious journals such as The Lancet, Nature Medicine and Nature Genetics.

In The Last Decade

Sorena Nadaf

25 papers receiving 6.4k citations

Hit Papers

Production of vascular endothelial growth factor by human... 1996 2026 2006 2016 1996 1998 1998 2000 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sorena Nadaf United States 20 3.7k 3.2k 2.7k 884 682 26 6.5k
Kimberly R. Kalli United States 46 1.6k 0.4× 2.1k 0.7× 2.2k 0.8× 1.1k 1.3× 387 0.6× 101 5.5k
Christina M. Annunziata United States 37 1.2k 0.3× 2.6k 0.8× 2.5k 0.9× 1.0k 1.1× 531 0.8× 155 5.4k
Peter Blume‐Jensen United States 18 840 0.2× 1.3k 0.4× 3.3k 1.2× 454 0.5× 561 0.8× 25 5.0k
Otávia L. Caballero United States 38 2.8k 0.8× 3.1k 1.0× 4.9k 1.8× 1.4k 1.6× 615 0.9× 74 7.9k
Lalita A. Shevde United States 41 1.3k 0.3× 2.5k 0.8× 4.5k 1.7× 1.6k 1.8× 1.0k 1.5× 105 6.9k
Y. Gloria Meng United States 31 3.0k 0.8× 2.2k 0.7× 4.8k 1.8× 948 1.1× 586 0.9× 48 8.6k
Paulette Mhawech‐Fauceglia United States 35 1.6k 0.4× 2.0k 0.6× 1.9k 0.7× 689 0.8× 676 1.0× 126 5.0k
Göran Jönsson Sweden 38 1.1k 0.3× 2.2k 0.7× 2.5k 0.9× 1.2k 1.3× 630 0.9× 118 4.7k
Hagen Kulbe Germany 27 2.6k 0.7× 2.1k 0.7× 1.3k 0.5× 834 0.9× 289 0.4× 67 4.4k
Jennifer L. Hsu United States 29 1.7k 0.5× 2.4k 0.7× 2.7k 1.0× 1.3k 1.5× 791 1.2× 62 5.1k

Countries citing papers authored by Sorena Nadaf

Since Specialization
Citations

This map shows the geographic impact of Sorena Nadaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sorena Nadaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sorena Nadaf more than expected).

Fields of papers citing papers by Sorena Nadaf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sorena Nadaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sorena Nadaf. The network helps show where Sorena Nadaf may publish in the future.

Co-authorship network of co-authors of Sorena Nadaf

This figure shows the co-authorship network connecting the top 25 collaborators of Sorena Nadaf. A scholar is included among the top collaborators of Sorena Nadaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sorena Nadaf. Sorena Nadaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barnholtz‐Sloan, Jill S., Dana E. Rollison, Amrita Basu, et al.. (2020). Cancer Informatics for Cancer Centers (CI4CC): Building a Community Focused on Sharing Ideas and Best Practices to Improve Cancer Care and Patient Outcomes. JCO Clinical Cancer Informatics. 4(4). 108–116. 2 indexed citations
2.
Ohm, Joyce E., Dmitry I. Gabrilovich, Gregory D. Sempowski, et al.. (2016). VEGF inhibits T cell development and may contribute to tumor-induced immune suppression Running title: VEGF induces dramatic thymic atrophy.
3.
Rauen, Katherine A., Anuradha Banerjee, W. Robert Bishop, et al.. (2011). Costello and cardio‐facio‐cutaneous syndromes: Moving toward clinical trials in RASopathies. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 157(2). 136–146. 41 indexed citations
4.
Csiki, Ildiko, Kiyoshi Yanagisawa, Nobuhiro Haruki, et al.. (2006). Thioredoxin-1 Modulates Transcription of Cyclooxygenase-2 via Hypoxia-Inducible Factor-1α in Non–Small Cell Lung Cancer. Cancer Research. 66(1). 143–150. 79 indexed citations
5.
Dikov, Mikhail M., Joyce E. Ohm, Neelanjan Ray, et al.. (2005). Differential Roles of Vascular Endothelial Growth Factor Receptors 1 and 2 in Dendritic Cell Differentiation. The Journal of Immunology. 174(1). 215–222. 199 indexed citations
6.
Khabiri, Alireza, et al.. (2005). Leishmanin skin test in guinea pig with a single purified protein of Leishmania major. Experimental Parasitology. 111(4). 239–243. 5 indexed citations
7.
Carbone, David P., I. Frank Ciernik, Michael J. Kelley, et al.. (2005). Immunization With Mutantp53- andK-ras–Derived Peptides in Cancer Patients: Immune Response and Clinical Outcome. Journal of Clinical Oncology. 23(22). 5099–5107. 127 indexed citations
8.
Nadaf, Sorena, et al.. (2004). Prenatal Diagnosis of Congenital Toxoplasmosis: Validity of PCR Using Amniotic Fluid against Indirect Fluorescent Antibody Assay in Mothers. Majallah-i bihdāsht-i Īrān. 33(1). 1–4. 5 indexed citations
9.
Lee, Choon-Taek, Kyungho Park, Kiyoshi Yanagisawa, et al.. (2004). Combination Therapy with Conditionally Replicating Adenovirus and Replication Defective Adenovirus. Cancer Research. 64(18). 6660–6665. 41 indexed citations
10.
Yanagisawa, Kiyoshi, Yu Shyr, Baogang Xu, et al.. (2003). Proteomic patterns of tumour subsets in non-small-cell lung cancer. The Lancet. 362(9382). 433–439. 455 indexed citations
11.
Min, Yongfen, Yasushi Adachi, Hiroyuki Yamamoto, et al.. (2003). Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer.. PubMed. 63(19). 6432–41. 76 indexed citations
12.
Adachi, Yasushi, Choon‐Taek Lee, Keith Coffee, et al.. (2002). Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines. Gastroenterology. 123(4). 1191–1204. 77 indexed citations
13.
Nadaf, Sorena, et al.. (2000). DETECTION OF TOXOPLASMA GONDII IN DEAD FETUSES BY POLYMERASE CHAIN REACTION (PCR). 25(12). 59–61. 3 indexed citations
14.
Oyama, Tsunehiro, Sophia Ran, Tadao Ishida, et al.. (1998). Vascular Endothelial Growth Factor Affects Dendritic Cell Maturation Through the Inhibition of Nuclear Factor-κB Activation in Hemopoietic Progenitor Cells. The Journal of Immunology. 160(3). 1224–1232. 402 indexed citations
15.
Gabrilovich, Dmitry I., Tadao Ishida, Tsunehiro Oyama, et al.. (1998). Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo. Blood. 92(11). 4150–4166. 734 indexed citations breakdown →
16.
Gabrilovich, Dmitry I., Tadao Ishida, Tsunehiro Oyama, et al.. (1998). Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo. Blood. 92(11). 4150–4166. 784 indexed citations breakdown →
17.
Oyama, Tsunehiro, Sophia Ran, Tadao Ishida, et al.. (1998). Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells.. PubMed. 160(3). 1224–32. 446 indexed citations
18.
Gabrilovich, Dmitry I., et al.. (1996). Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Medicine. 2(10). 1096–1103. 1549 indexed citations breakdown →
19.
Gabrilovich, Dmitry I., et al.. (1996). Dendritic Cells in Antitumor Immune Responses. Cellular Immunology. 170(1). 111–119. 179 indexed citations
20.
Gabrilovich, Dmitry I., et al.. (1996). A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer. Nature Genetics. 13(2). 210–213. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026